Advertisement
Screener

NATERA, INC. (NTRA) Financing Cash Flow

2.8 / 5 stars · 68/120 Roast Me

NATERA, INC. Financing Cash Flow

NATERA, INC. (NTRA) reported Financing Cash Flow of $15.96 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.

Financial Statements › Cash Flow › Financing Activities

us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-07

  • NATERA, INC. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $12.21M, a 2.94% decline year-over-year.
  • NATERA, INC. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $3.76M, a 590.81% increase year-over-year.
  • NATERA, INC. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $32.41M, a 195.30% increase year-over-year.
  • NATERA, INC. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $1.94M, a 12.50% increase year-over-year.
  • NATERA, INC. net cash provided by (used in) financing activities for fiscal 2025 was $47.46M, a 57.13% increase from fiscal 2024.
  • NATERA, INC. net cash provided by (used in) financing activities for fiscal 2024 was $30.20M, a 88.13% decline from fiscal 2023.
  • NATERA, INC. net cash provided by (used in) financing activities for fiscal 2023 was $254.46M, a 47.28% decline from fiscal 2022.
  • NATERA, INC. net cash provided by (used in) financing activities for fiscal 2022 was $482.64M, a 16.24% decline from fiscal 2021.
Period endNet Cash Provided by (Used in) Financing Activities 3 monthNet Cash Provided by (Used in) Financing Activities 3 month as first filedNet Cash Provided by (Used in) Financing Activities 6 monthNet Cash Provided by (Used in) Financing Activities 9 monthNet Cash Provided by (Used in) Financing Activities 12 month
2026-06-30$12.21M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07
$15.96M
10-Q · filed 2026-08-07
$48.37M
derived: sum of 3 quarters · filed 2026-08-07
$50.30M
derived: sum of 4 quarters · filed 2026-08-07
2026-03-31$3.76M
10-Q · filed 2026-05-08
$36.16M
derived: sum of 2 quarters · filed 2026-05-08
$38.10M
derived: sum of 3 quarters · filed 2026-05-08
$50.67M
derived: sum of 4 quarters · filed 2026-08-07
2025-12-31$32.41M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
$34.34M
derived: sum of 2 quarters · filed 2026-02-27
$46.92M
derived: sum of 3 quarters · filed 2026-08-07
$47.46M
10-K · filed 2026-02-27
2025-09-30$1.94M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07
$14.51M
derived: sum of 2 quarters · filed 2026-08-07
$15.05M
10-Q · filed 2025-11-07
$26.03M
derived: sum of 4 quarters · filed 2026-08-07
2025-06-30$12.58M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07
$13.12M
10-Q · filed 2026-08-07
$24.09M
derived: sum of 3 quarters · filed 2026-08-07
$25.81M
derived: sum of 4 quarters · filed 2026-08-07
2025-03-31$544.00K
10-Q · filed 2026-05-08
$11.52M
derived: sum of 2 quarters · filed 2026-05-08
$13.24M
derived: sum of 3 quarters · filed 2026-05-08
$24.28M
derived: sum of 4 quarters · filed 2026-05-08
2024-12-31$10.97M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
$12.69M
derived: sum of 2 quarters · filed 2026-02-27
$23.74M
derived: sum of 3 quarters · filed 2026-02-27
$30.20M
10-K · filed 2026-02-27
2024-09-30$1.72M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07
$12.76M
derived: sum of 2 quarters · filed 2025-11-07
$19.23M
10-Q · filed 2025-11-07
$26.07M
derived: sum of 4 quarters · filed 2026-02-27
2024-06-30$11.04M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08
$17.51M
10-Q · filed 2025-08-08
$24.36M
derived: sum of 3 quarters · filed 2026-02-27
$260.36M
derived: sum of 4 quarters · filed 2026-02-27
2024-03-31$6.47M
10-Q · filed 2025-05-09
$13.31M
derived: sum of 2 quarters · filed 2026-02-27
$249.31M
derived: sum of 3 quarters · filed 2026-02-27
$258.63M
derived: sum of 4 quarters · filed 2026-02-27
2023-12-31$6.84M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
$242.85M
derived: sum of 2 quarters · filed 2026-02-27
$252.16M
derived: sum of 3 quarters · filed 2026-02-27
$254.46M
10-K · filed 2026-02-27
2023-09-30$236.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12
$245.31M
derived: sum of 2 quarters · filed 2024-11-12
$247.62M
10-Q · filed 2024-11-12
$715.79M
derived: sum of 4 quarters · filed 2025-02-28
2023-06-30$9.31M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09
$11.61M
10-Q · filed 2024-08-09
$479.79M
derived: sum of 3 quarters · filed 2025-02-28
$481.18M
derived: sum of 4 quarters · filed 2025-02-28
2023-03-31$2.30M
10-Q · filed 2024-05-10
$470.47M
derived: sum of 2 quarters · filed 2025-02-28
$471.87M
derived: sum of 3 quarters · filed 2025-02-28
$480.79M
derived: sum of 4 quarters · filed 2025-02-28
2022-12-31$468.17M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28
$469.57M
derived: sum of 2 quarters · filed 2025-02-28
$478.48M
derived: sum of 3 quarters · filed 2025-02-28
$482.64M
10-K · filed 2025-02-28
2022-09-30$1.39M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09
$10.31M
derived: sum of 2 quarters · filed 2023-11-09
$14.47M
10-Q · filed 2023-11-09
$22.98M
derived: sum of 4 quarters · filed 2024-02-29
2022-06-30$8.92M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04
$13.07M
10-Q · filed 2023-08-04
$21.59M
derived: sum of 3 quarters · filed 2024-02-29
$576.35M
derived: sum of 4 quarters · filed 2024-02-29
2022-03-31$4.16M
10-Q · filed 2023-05-10
$12.67M
derived: sum of 2 quarters · filed 2024-02-29
$567.43M
derived: sum of 3 quarters · filed 2024-02-29
$575.77M
derived: sum of 4 quarters · filed 2024-02-29
2021-12-31$8.52M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29
$563.27M
derived: sum of 2 quarters · filed 2024-02-29
$571.62M
derived: sum of 3 quarters · filed 2024-02-29
$576.19M
10-K · filed 2024-02-29
2021-09-30$554.76M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09
$563.10M
derived: sum of 2 quarters · filed 2022-11-09
$567.67M
10-Q · filed 2022-11-09
$579.47M
derived: sum of 4 quarters · filed 2023-03-01
2021-06-30$8.34M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05
$12.91M
10-Q · filed 2022-08-05
$24.71M
derived: sum of 3 quarters · filed 2023-03-01
$300.33M
derived: sum of 4 quarters · filed 2023-03-01
2021-03-31$4.57M
10-Q · filed 2022-05-06
$16.36M
derived: sum of 2 quarters · filed 2023-03-01
$291.99M
derived: sum of 3 quarters · filed 2023-03-01
$501.59M
derived: sum of 4 quarters · filed 2023-03-01
2020-12-31$11.79M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01
$287.42M
derived: sum of 2 quarters · filed 2023-03-01
$497.02M
derived: sum of 3 quarters · filed 2023-03-01
$500.85M
10-K · filed 2023-03-01
2020-09-30$275.62M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05
$485.23M
derived: sum of 2 quarters · filed 2021-11-05
$489.05M
10-Q · filed 2021-11-05
$709.67M
derived: sum of 4 quarters · filed 2022-02-25
2020-06-30$209.60M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06
$213.43M
10-Q · filed 2021-08-06
$434.05M
derived: sum of 3 quarters · filed 2022-02-25
$554.20M
derived: sum of 4 quarters · filed 2022-02-25
2020-03-31$3.83M
10-Q · filed 2021-05-07
$224.44M
derived: sum of 2 quarters · filed 2022-02-25
$344.60M
derived: sum of 3 quarters · filed 2022-02-25
$460.32M
derived: sum of 4 quarters · filed 2022-02-25
2019-12-31$220.62M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25
$340.77M
derived: sum of 2 quarters · filed 2022-02-25
$456.50M
derived: sum of 3 quarters · filed 2022-02-25
$340.77M
10-K · filed 2022-02-25
2019-09-30$120.16M
10-Q · filed 2020-11-06
$235.88M
derived: sum of 2 quarters · filed 2020-11-06
$120.16M
10-Q · filed 2019-11-08
$241.49M
derived: sum of 4 quarters · filed 2021-02-26
2019-06-30$115.72M
10-Q · filed 2020-08-07
$115.72M
10-Q · filed 2019-08-09
$121.33M
derived: sum of 3 quarters · filed 2021-02-26
$225.98M
derived: sum of 4 quarters · filed 2021-02-26
2019-03-31$2.58M
10-Q · filed 2020-05-08
$5.61M
derived: sum of 2 quarters · filed 2021-02-26
$110.25M
derived: sum of 3 quarters · filed 2021-02-26
$115.74M
derived: sum of 4 quarters · filed 2021-02-26
2018-12-31$3.03M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26
$107.67M
derived: sum of 2 quarters · filed 2021-02-26
$113.16M
derived: sum of 3 quarters · filed 2021-02-26
$113.72M
10-K · filed 2021-02-26
2018-09-30$104.64M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08
$110.13M
derived: sum of 2 quarters · filed 2019-11-08
$110.69M
10-Q · filed 2019-11-08
$112.73M
derived: sum of 4 quarters · filed 2020-03-02
2018-06-30$5.49M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09
$6.05M
10-Q · filed 2019-08-09
$8.09M
derived: sum of 3 quarters · filed 2020-03-02
$83.98M
derived: sum of 4 quarters · filed 2020-03-02
2018-03-31$564.00K
10-Q · filed 2019-05-10
$565.00K
10-Q · filed 2018-05-10
$2.60M
derived: sum of 2 quarters · filed 2020-03-02
$78.49M
derived: sum of 3 quarters · filed 2020-03-02
$80.52M
derived: sum of 4 quarters · filed 2020-03-02
2017-12-31$2.04M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02
$77.93M
derived: sum of 2 quarters · filed 2020-03-02
$79.96M
derived: sum of 3 quarters · filed 2020-03-02
$80.37M
10-K · filed 2020-03-02
2017-09-30$75.89M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09
$77.92M
derived: sum of 2 quarters · filed 2018-11-09
$78.34M
10-Q · filed 2018-11-09
$80.83M
derived: sum of 4 quarters · filed 2019-03-15
2017-06-30$2.03M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09
$2.44M
10-Q · filed 2018-08-09
$4.93M
derived: sum of 3 quarters · filed 2019-03-15
$5.39M
derived: sum of 4 quarters · filed 2019-03-15
2017-03-31$413.00K
10-Q · filed 2018-05-10
$2.90M
derived: sum of 2 quarters · filed 2019-03-15
$3.36M
derived: sum of 3 quarters · filed 2019-03-15
2016-12-31$2.49M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15
$2.95M
derived: sum of 2 quarters · filed 2019-03-15
$13.18M
10-K · filed 2019-03-15
2016-09-30$454.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09
$10.69M
10-Q · filed 2017-11-09
2016-06-30$10.24M
10-Q · filed 2017-08-09
2015-12-31$190.28M
10-K · filed 2018-03-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
QUEST DIAGNOSTICS INC (DGX)United States$26.096B22.09
LABCORP HOLDINGS INC. (LH)United States$25.060B22.60
Guardant Health, Inc. (GH)United States$23.675B-12.65
Caris Life Sciences, Inc. (CAI)United States$9.119B47.87
RadNet, Inc. (RDNT)United States$5.611B-229.65
GRAIL, Inc. (GRAL)United States$5.591B-7.78
VERACYTE, INC. (VCYT)United States$3.904B41.21
Celcuity Inc. (CELC)United States$3.887B-22.62
CareDx, Inc. (CDNA)United States$3.174B13.21
Fortrea Holdings Inc. (FTRE)United States$1.903B-19.43